drugset / Trial / NCT06706271

The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease

NCT06706271

Phase 2/3 Completed 43 enrolled Hasanuddin University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to analyze the effects of in vitamin D3 on serum hepcidin and ferritin levels among children with chronic kidney disease. The main questions it aims to answer is: "What is the effect of giving vitamin D3 on serum hepcidin and ferritin levels in children with chronic kidney disease?" We will compare the effect of vitamin D3 administration on hepcidin and ferritin between 2 groups. Group A consists of children with GFR more 90 mL/min/1,73 m2. Group B consists of children with GFR less than 90 mL/min/1,73 m2 Participants will be given the same 2000 IU of Vitamin D/day for 6 weeks.

Timeline

Start
2023-05-01
Primary completion
2024-08-01
Completion
2024-09-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 2000 iu